이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Effect of Redon-type Drains on Postoperative Edema Following Mandibular Orthognathic Surgery: a Randomized, Controlled Superiority Trial With Two Parallel Arms (DPO - OM)

2026년 11월 11일 업데이트: University Hospital, Tours

Orthognathic surgery involves the maxillary and/or mandibular skeletal bases; it entails maxillary and/or mandibular osteotomies (such as sagittal split osteotomies of the mandibular rami) aimed at restoring normal maxillomandibular skeletal and dento-occlusal relationships in patients with maxillomandibular dysmorphosis. These deformities give rise to morphological, aesthetic, and functional abnormalities that can be severe (e.g., respiratory issues, temporomandibular joint pain). Postoperative edema is inevitable following orthognathic surgery; it can be significant, causing pain and discomfort while delaying patient recovery and hospital discharge. The use of Redon-type drains for mandibular osteotomies is not a standard practice across surgical teams due to a lack of consensus. The only available data come from studies with methodologies that do not allow for a definitive conclusion regarding the superiority of using-or not using-postoperative Redon drains (Lee et al. 2020), and no clinical trials have investigated this issue. This project aims to evaluate the impact of Redon-type drainage in mandibular osteotomies (sagittal split osteotomies of the mandibular rami), whether or not combined with genioplasty (osteotomy of the mental symphysis). We hypothesize that drainage using Redon-type drains for 6 hours in the immediate postoperative period following mandibular osteotomies significantly reduces postoperative edema.

The primary objective of this clinical trial is to demonstrate the superiority-in terms of reducing postoperative edema at day 2-of placing Redon-type drains for 6 hours immediately following sagittal split osteotomy of the mandibular rami (in addition to standard postoperative care) compared to standard postoperative care alone, without a drainage device.

Hypothesis: Demonstrating that the use of Redon-type drains following orthognathic surgery osteotomies reduces postoperative edema, pain, and discomfort would provide a rational basis for this practice and support its routine implementation. The expected benefits are twofold, impacting both patients and public health. For patients, the anticipated benefits include reduced postoperative discomfort and pain, faster recovery, and shorter hospital stays, with the future prospect of outpatient care.

연구 개요

연구 유형

중재적

등록 (추정된)

72

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 장소

      • Angers, 프랑스
        • Chu Angers
      • Nantes, 프랑스
        • Chu Nantes

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

15년 이상 (어린이, 성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion criteria:

  • Patients aged 15 years or older

  • Undergoing mandibular osteotomies, with or without genioplasty, with or without wisdom tooth extraction (maxillary and/or mandibular)

  • Informed consent obtained from the adult patient, or from the holder(s) of parental authority if the patient is a minor*

  • Enrolled in a French social security program

    • When both holders of parental authority cannot give joint consent, the consent of a single legal representative may be obtained in situations provided for by regulations or duly justified and documented in the source file.

Exclusion Criteria:

  • History of maxillomandibular bone surgery
  • Coagulation disorder
  • Thrombophilia
  • Patients on anticoagulants or antiplatelet agents
  • Patients with a constitutional bone disorder
  • Patients with a syndromic craniofacial malformation
  • Absolute or relative contraindications to treatment with corticosteroids
  • Pregnant (urine test) or breastfeeding women
  • Patients under legal guardianship, conservatorship, or judicial protection
  • Contraindications to the procedure
  • Patients who have taken corticosteroids or NSAIDs on the day before the procedure (D-1).

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 방지
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: experimental arm

with drains placed at the end of the procedure, in addition to standard postoperative care. These will be Redon drains with an outlet that is either intraoral or transcutaneous in the cervical region, depending on the participating center's practices (intraoral transmucosal in the Tours and Angers centers or transcutaneous in the Nantes center); these drains will be removed 6 hours after placement

Translated with DeepL.com (free version)

in which drains are placed at the end of the procedure, in addition to standard postoperative care.

활성 비교기: control arm

which consists of not placing any drainage device immediately after surgery, with standard postoperative care identical to that of the experimental group.

not placing any drainage device immediately after surgery, with standard postoperative care identical

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Postoperative swelling
기간: Cervicofacial linear measurement will be collected 48 hours after the randomization (day 2) and at month 3. As the facial skeletal anatomy will be modified by the surgical procedure, month 3 will be considered as the baseline measurement.

The primary outcome will be the post operative facial swelling 48 hours after the end of the surgical procedure (randomization will be at this timepoint) measured with cervicofacial linear measurements

Cervicofacial linear measurement will be collected 48 hours after the randomization (day 2) and at month 3. As the facial skeletal anatomy will be modified by the surgical procedure, month 3 will be considered as the baseline measurement.

2차 결과 측정

결과 측정
측정값 설명
기간
Postoperative swelling
기간: Cervicofacial linear measurement will be collected at 6 hours after randomization, 24 hours after randomization (day 1) and at day 7

Postoperative swelling at other time points than for the primary outcome, measured with cervico facial linear measurements

Cervicofacial linear measurement will be collected at 6 hours after randomization, 24 hours after randomization (day 1) and at day 7
Postoperative swelling
기간: It will be collected 24 hours after randomization (day 1) , at day 2, at day 7 and at month 3

Postoperative swelling using 3D photogrammetry instead of cervicofacial linear measurements

It will be collected 24 hours after randomization (day 1) , at day 2, at day 7 and at month 3
Pain intensity
기간: Pain will be collected 6 hours after randomization, at day 1 (24 hours after randomization), at day 2 and at day 7

Pain will be measured using a visual analog scale where 0 corresponds to no pain and 10 to unbearable pain

Pain will be collected 6 hours after randomization, at day 1 (24 hours after randomization), at day 2 and at day 7
Aesthetic discomfort
기간: It will be collected 6 hours after randomization, at day 1 (24 hours after randomization), at day 2 and at day 7

Aesthetic discomfort will be measured using a visual analog scale with 0 indicating no discomfort and 10 corresponding to an extremely uncomfortable feeling

It will be collected 6 hours after randomization, at day 1 (24 hours after randomization), at day 2 and at day 7
Breathing discomfort
기간: It will be collected 6 hours after randomization, at day 1 (24 hours after randomization), at day 2 and at day 7

Breathing discomfort will be measured using a visual analog scale where 0 corresponds to no discomfort and 10 to extremely bothersome

It will be collected 6 hours after randomization, at day 1 (24 hours after randomization), at day 2 and at day 7
Swallowing discomfort
기간: It will be collected 6 hours after randomization, at day 1 (24 hours after randomization), at day 2 and at day 7

Swallowing discomfort will be measured using a visual analog scale where 0 corresponds to no discomfort and 10 to extremely bothersome

It will be collected 6 hours after randomization, at day 1 (24 hours after randomization), at day 2 and at day 7
Pain during redon drain removal
기간: It will be collected 6 hours after randomization, at time to redon removal.

Pain during redon drain removal will be collected for participants of the experimental group after redon drain removal

It will be collected 6 hours after randomization, at time to redon removal.
The daily bed rest in hours
기간: It will be collected at day 1 and at day 2 (how long the participant stay in his bed in the last 24 hours) as well as at day 7 (how long the participants stay in his bed each day of the last 4 days).

It corresponds to how long, in hours, the participant stays in his bed each day.

It will be collected at day 1 and at day 2 (how long the participant stay in his bed in the last 24 hours) as well as at day 7 (how long the participants stay in his bed each day of the last 4 days).
The general well-being
기간: It will be collected at day 7 and at month 3

General well-being will be assessed using the GHQ-28 self-assessment questionnaire. The GHQ-28 is a questionnaire with 28 items and with scores ranging from 0 - indicating no deterioration in well-being - to 84 - indicating a significant deterioration in well-being.

It will be collected at day 7 and at month 3
The length of hospital stay
기간: a maximum of 90 days

It corresponds to the lenght of the hospital stay, in days (a maximum of 90 days)

a maximum of 90 days
Postoperative adverse events
기간: Throughout the three-month follow-up period, whenever an adverse event occurs

Postoperative adverse events correspond to hematoma, pre-thoracic hematoma spread, and infection

Throughout the three-month follow-up period, whenever an adverse event occurs

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 연구 책임자: Anne MORICE, Dr, University Hospital, Tours

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 12월 30일

기본 완료 (추정된)

2029년 12월 30일

연구 완료 (추정된)

2030년 3월 28일

연구 등록 날짜

최초 제출

2026년 10월 6일

QC 기준을 충족하는 최초 제출

2026년 11월 11일

처음 게시됨 (실제)

2026년 11월 12일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 12일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 11일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다